Is a BTKi or BCL2i preferable for first “novel” therapy in CLL? The case for BTKis

por Brem, Elizabeth A., O’Brien, Susan
Publicado 2022

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

por Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
Publicado 2010

Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem...

por Coombs, Catherine C., Easaw, Saumya, Grover, Natalie S., O’Brien, Susan M.
Publicado 2023

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

por Bar-Or, Amit, O’Brien, Susan M., Sweeney, Michael L., Fox, Edward J., Cohen, Jeffrey A.
Publicado 2021

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

por Salles, Gilles, Barrett, Martin, Foà, Robin, Maurer, Joerg, O’Brien, Susan, Valente, Nancy, Wenger, Michael, Maloney, David G.
Publicado 2017

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice

por O’Brien, Susan M., Brown, Jennifer R., Byrd, John C., Furman, Richard R., Ghia, Paolo, Sharman, Jeff P., Wierda, William G.
Publicado 2021

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)

por Eichhorst, Barbara, Lamanna, Nicole, O’brien, Susan, Tam, Constantine, Qiu, Lugui, Yang, Keri, Wu, Ken, Salmi, Tommi, Barnes, Gisoo, Brown, Jennifer R.
Publicado 2023

JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms

por Ma, Wanlong, Kantarjian, Hagop, Zhang, Xi, Wang, Xiuqiang, Zhang, Zhong, Yeh, Chen-Hsiung, O'Brien, Susan, Giles, Francis, Bruey, Jean Marie, Albitar, Maher
Publicado 2010

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials

por Allan, John N., Shanafelt, Tait, Wiestner, Adrian, Moreno, Carol, O’Brien, Susan M., Li, Jianling, Krigsfeld, Gabriel, Dean, James P., Ahn, Inhye E.
Publicado 2021

"Sleepiness" is serious in adolescence: Two surveys of 3235 Canadian students

por Gibson, Edward S, Powles, AC Peter, Thabane, Lehana, O'Brien, Susan, Molnar, Danielle Sirriani, Trajanovic, Nik, Ogilvie, Robert, Shapiro, Colin, Yan, Mi, Chilcott-Tanser, Lisa
Publicado 2006

Phase II, Open Label, Randomized Comparative Trial of Ondansetron Alone versus the Combination of Ondansetron and Aprepitant for the Prevention of Nausea and Vomiting in Patients w...

por Badar, Talha, Cortes, Jorge, Borthakur, Gautam, O'Brien, Susan, Wierda, William, Garcia-Manero, Guillermo, Ferrajoli, Alessandra, Kadia, Tapan, Poku, Rebeca, Kantarjian, Hagop, Mattiuzzi, Gloria
Publicado 2015

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas

por Cheson, Bruce D., O’Brien, Susan, Ewer, Michael S., Goncalves, Marcus D., Farooki, Azeez, Lenz, Georg, Yu, Anthony, Fisher, Richard I., Zinzani, Pierre L., Dreyling, Martin
Publicado 2018

The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia

por de Jong, Jan, Sukbuntherng, Juthamas, Skee, Donna, Murphy, Joe, O’Brien, Susan, Byrd, John C., James, Danelle, Hellemans, Peter, Loury, David J., Jiao, Juhui, Chauhan, Vijay, Mannaert, Erik
Publicado 2015

Prospective Analysis: Relative Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Era of Tyrosine Kinase Inhibitors

por Sasaki, Koji, Strom, Sara S., O’Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Konopleva, Marina, Borthakur, Gautam, Pemmaraju, Naveen, Daver, Naval, Jain, Preetesh, Pierce, Sherry, Kantarjian, Hagop, Cortes, Jorge E.
Publicado 2015

Winter locations of red‐throated divers from geolocation and feather isotope signatures

por Duckworth, James, O'Brien, Susan, Petersen, Ib K., Petersen, Aevar, Benediktsson, Guðmundur, Johnson, Logan, Lehikoinen, Petteri, Okill, David, Väisänen, Roni, Williams, Jim, Williams, Stuart, Daunt, Francis, Green, Jonathan A.
Publicado 2022

Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome

por Ma, Wanlong, Kantarjian, Hagop, Zhang, Ke, Zhang, Xi, Wang, Xiuqiang, Chen, Clifford, Donahue, Amber C, Zhang, Zhong, Yeh, Chen-Hsiung, O'Brien, Susan, Garcia-Manero, Guillermo, Caporaso, Neil, Landgren, Ola, Albitar, Maher
Publicado 2010

Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO...

por Kantarjian, Hagop M., DeAngelo, Daniel J., Stelljes, Matthias, Liedtke, Michaela, Stock, Wendy, Gökbuget, Nicola, O’Brien, Susan M., Jabbour, Elias, Wang, Tao, Liang White, Jane, Sleight, Barbara, Vandendries, Erik, Advani, Anjali S.
Publicado 2019

Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden

por DeAngelo, Daniel J., Advani, Anjali S., Marks, David I., Stelljes, Matthias, Liedtke, Michaela, Stock, Wendy, Gökbuget, Nicola, Jabbour, Elias, Merchant, Akil, Wang, Tao, Vandendries, Erik, Neuhof, Alexander, Kantarjian, Hagop, O’Brien, Susan
Publicado 2020

A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia

por Schweighofer, Carmen D., Coombes, Kevin R., Barron, Lynn L., Diao, Lixia, Newman, Rachel J., Ferrajoli, Alessandra, O'Brien, Susan, Wierda, William G., Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Keating, Michael J., Abruzzo, Lynne V.
Publicado 2011

The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia

por Nazha, Aziz, Bueso-Ramos, Carlos, Estey, Eli, Faderl, Stefan, O’Brien, Susan, Fernandez, Michael H., Nguyen, Martin, Koller, Charles, Freireich, Emil, Beran, Miloslav, Pierce, Sherry, Keating, Michael, Cortes, Jorge, Kantarjian, Hagop, Ravandi, Farhad
Publicado 2013